Literature DB >> 2881536

Covalently bound pyrroloquinoline quinone is the organic prosthetic group in human placental lysyl oxidase.

R A van der Meer, J A Duine.   

Abstract

Treatment of purified human placental lysyl oxidase with 2,4-dinitrophenylhydrazine (DNPH) resulted in a large spectral change and inhibition of enzyme activity. Proteolytic degradation of the derivatized enzyme yielded only one single coloured product, which was spectrally and chromatographically identical with the C-5 hydrazone of PQQ (pyrroloquinoline quinone) and DNPH. Since this represents the first example of a PQQ-containing enzyme in man, possible implications of the finding are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2881536      PMCID: PMC1147358          DOI: 10.1042/bj2390789

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Stability and purification of lysyl oxidase.

Authors:  A S Narayanan; R C Siegel; G R Martin
Journal:  Arch Biochem Biophys       Date:  1974-05       Impact factor: 4.013

Review 3.  Enzymology of quinoproteins.

Authors:  J A Duine; J Frank; J A Jongejan
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1987

Review 4.  Lysyl oxidase.

Authors:  R C Siegel
Journal:  Int Rev Connect Tissue Res       Date:  1979

5.  Use of triazine dyes in the affinity chromatographic purification of alkaline phosphatase from calf intestine.

Authors:  V Bouriotis; P D Dean
Journal:  J Chromatogr       Date:  1981-02-27

6.  Purification and properties of four species of lysyl oxidase from bovine aorta.

Authors:  H M Kagan; K A Sullivan; T A Olsson; A L Cronlund
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

7.  Molecular diseases of connective and vascular tissues. II. Amine oxidase inhibition by the lathyrogen, beta-aminopropionitrile.

Authors:  R C Page; E P Benditt
Journal:  Biochemistry       Date:  1967-04       Impact factor: 3.162

8.  Human placental lysyl oxidase. Purification, partial characterization, and preparation of two specific antisera to the enzyme.

Authors:  H Kuivaniemi; E R Savolainen; K I Kivirikko
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

9.  Bovine serum amine oxidase: a mammalian enzyme having covalently bound PQQ as prosthetic group.

Authors:  C L Lobenstein-Verbeek; J A Jongejan; J Frank; J A Duine
Journal:  FEBS Lett       Date:  1984-05-21       Impact factor: 4.124

10.  Reaction of aortic lysyl oxidase with beta-aminopropionitrile.

Authors:  S S Tang; P C Trackman; H M Kagan
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

View more
  10 in total

1.  Pyridinedicarboxylates, the first mechanism-derived inhibitors for prolyl 4-hydroxylase, selectively suppress cellular hydroxyprolyl biosynthesis. Decrease in interstitial collagen and Clq secretion in cell culture.

Authors:  G Tschank; M Raghunath; V Günzler; H M Hanauske-Abel
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

2.  Purification of lysyl oxidase from piglet skin by selective interaction with Sephacryl S-200.

Authors:  D R Shackleton; D J Hulmes
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

3.  Production of pyrroloquinoline quinone by using methanol-utilizing bacteria.

Authors:  T Urakami; K Yashima; H Kobayashi; A Yoshida; C Ito-Yoshida
Journal:  Appl Environ Microbiol       Date:  1992-12       Impact factor: 4.792

Review 4.  PQQ and quinoproteins: an important novel field in enzymology.

Authors:  J A Duine
Journal:  Antonie Van Leeuwenhoek       Date:  1989-05       Impact factor: 2.271

Review 5.  Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential.

Authors:  H Chen; J Rhodes
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

6.  Factors affecting the production of pyrroloquinoline quinone by the methylotrophic bacterium W3A1.

Authors:  W S McIntire; W Weyler
Journal:  Appl Environ Microbiol       Date:  1987-09       Impact factor: 4.792

7.  PQQ: biosynthetic studies in Methylobacterium AM1 and Hyphomicrobium X using specific 13C labeling and NMR.

Authors:  D R Houck; J L Hanners; C J Unkefer; M A van Kleef; J A Duine
Journal:  Antonie Van Leeuwenhoek       Date:  1989-05       Impact factor: 2.271

8.  Steady-state kinetic analysis of the quinoprotein methylamine dehydrogenase from Paracoccus denitrificans.

Authors:  V L Davidson
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

9.  Levels of pyrroloquinoline quinone in various foods.

Authors:  T Kumazawa; K Sato; H Seno; A Ishii; O Suzuki
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

10.  Structure of quinoprotein methylamine dehydrogenase at 2.25 A resolution.

Authors:  F M Vellieux; F Huitema; H Groendijk; K H Kalk; J F Jzn; J A Jongejan; J A Duine; K Petratos; J Drenth; W G Hol
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.